Participants in the Quality of Care and Outcomes Research (QCOR) in Cardiovascular Disease and Stroke conference play a major role in efforts to improve the quality of cardiovascular medical care and patient outcomes. It is the only major international meeting focused on cardiovascular issues in which clinical researchers interact in a meaningful way with policy makers and quality outcomes experts. The confluence of these three players is critical in today?s changing healthcare environment, in which quality and cost issues can no longer be divorced from the clinical care provided or from patient outcomes.
The quality improvement efforts that form the core of QCOR 2017 include an exploration of the future directions for the US healthcare system and the impact on cardiovascular disease management, as well as the role of Real-world evidence (RWE) generation for drugs and devices in the current regulatory environment. The target audience for this educational activity includes clinicians, researchers, medical students and trainees, nurses, pharmacists, administrators, healthcare and managed care professionals, policymakers and other healthcare professionals interested in quality of care and outcomes research in cardiovascular disease and stroke.
- Discuss the potential for focused quality improvement efforts to reduce variation, spread innovation, and significantly improve the quality of care in the cardiovascular arena, including identifying the key components that must be a part of all such efforts.
- Discuss MACRA and its 2 payment models, understand how to prepare for success in the 4 performance categories (quality, resource use, clinical practice improvement activities, and advancing care information), implement strategies to report under MIPS, examine the associated incentives and penalties, and understand the steps needed to begin the path to APMs.
- Identify different sources for RWE, describe the benefits of the use of RWE to guide clinical practice, discuss the challenges in generating RWE, understand the drivers of RWD policy and practice and discuss the implications associated with the use of RWE.
- Recognize opportunities to address identifiable, behavioral, and biological risk factors for CVD to meet the AHA definition of ideal cardiovascular health.
- The role of real world evidence generation in the 21st century
- MACRA, MIPS, ACA and 21st Century Cures
- Implementation science
- Circulation CQO Town Hall
- Quality of Care Workshop
Abstract Submission opens September 7, 2016!
View our Abstract Submission Guidelines (PDF) for tips on how to submit your best science.